SANA — Sana Biotechnology, Inc.

—
Nasdaq · Health Care · Biotechnology · CIK 1770121 ·
Last close
$1.88
Market Cap
$563.31M
52W High
$5.49
52W Low
$1.84
ADV30
2,946,839
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — 18,506,000 20,401,000 376,127,000 41,104,000 195,763,000
Jun 2026 0 — -65,420,000 -63,635,000 431,522,000 57,073,000 276,954,000
Mar 2026 0 — -48,614,000 -47,210,000 373,593,000 83,800,000 254,353,000
Dec 2025 0 — -61,199,000 -58,825,000 416,890,000 71,870,000 256,006,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-132,239,000
Investing CF
$-102,603,000
Financing CF
$220,644,000
CapEx
$-2,823,000
Dividends Paid
—
Buybacks
$-60,000
EPS Diluted TTM
$-0.76
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,959,861,000
Inventory
—
Receivables
—
ST Investments
$103,417,000
EBIT TTM
$-218,748,000
Pretax Income TTM
$-211,822,000
Interest Exp TTM
—
Analysts
7

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -205,708,000 -244,166,000 416,890,000 256,006,000 160,884,000 -143,828,000
Dec 2024 0 -270,832,000 -266,759,000 501,020,000 250,516,000 250,504,000 -223,153,000
Dec 2023 0 -286,127,000 -283,255,000 565,299,000 277,793,000 287,506,000 -253,582,000
Dec 2022 0 -272,564,000 -269,476,000 822,720,000 323,405,000 499,315,000 -290,050,000

TTM Snapshot

Revenues TTM
$0
NetIncome TTM
$-211,822,000
OpCashFlow TTM
—
Assets (Latest)
$431,522,000
Forward EPS
$-0.56

Max Pain — expiry 2027-01-15

max pain strike: $2.00 · spot: $1.85 · call oi: 3,439 · put oi: 1,194
Expected Move to 2027-01-15: ±$1.15 (62.16%) — implied range $0.70 – $3.00 · ATM straddle on $2.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
SRZN Surrozen, Inc./DE $571.47M $29.98 —
VALN Valneva SE $527.69M $5.57 —
CGEM Cullinan Therapeutics, Inc. $602.14M $9.27 —
ETRA Electra Therapeutics, Inc. $524.10M $8.35 —
ENTX Entera Bio Ltd. $521.77M $3.00 —

News headlines (Yahoo Finance, 1h cache)

Bears are Losing Control Over Sana (SANA), Here's Why It's a 'Buy' Now
2026-11-16 13:55 · Yahoo
Sana: Q3 Earnings Snapshot
2026-11-05 23:01 · Yahoo
Sana Biotechnology Reports Third Quarter 2026 Financial Results and Business Updates
2026-11-05 21:05 · Yahoo
Sana Biotechnology to Present at September 2026 Investor Conferences
2026-09-01 20:05 · Yahoo
Sana Biotechnology (SANA) Publishes 14 Month Diabetes Cell Therapy Results In NEJM
2026-07-16 21:11 · Yahoo
Sana (SANA) Upgraded to Buy: Here's What You Should Know
2026-07-15 16:00 · Yahoo
Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026
2026-07-01 13:00 · Yahoo
Sana Biotech (SANA), Mayo Clinic Partner to Advance Cell Therapy for Type 1 Diabetes
2026-04-27 06:22 · Yahoo
Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference
2026-05-05 20:05 · Yahoo
Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting
2026-04-27 20:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.